QTc Study of Rosi XR in Healthy Volunteers

NCT00884533 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped The whole project was terminated

Conditions

Alzheimer's Disease

Interventions

DRUG: Rosi XR
OTHER: Placebo
DRUG: Moxifloxacin

Sponsor

GlaxoSmithKline